Sec. 202. Extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases
32 words·~1 min read·
/bill/118/hr/9747/rds/section-202A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Section 529(b)(5) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360ff(b)(5) ) is amended by striking September 30, 2024 each place it appears and inserting December 20, 2024 .
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 202
Extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases
Cites 1Cited by 0 across 0 sources